159 related articles for article (PubMed ID: 2444724)
1. Tumor immunology.
Kagan JM; Fahey JL
JAMA; 1987 Nov; 258(20):2988-92. PubMed ID: 2444724
[No Abstract] [Full Text] [Related]
2. Symposium on diagnosis and treatment of cancer. Recent progress.
Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
[No Abstract] [Full Text] [Related]
3. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
4. Tumor immunology at the service of cancer immunotherapy.
Finn OJ
Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
[No Abstract] [Full Text] [Related]
5. Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.
Malyguine A; Umansky V; Shurin MR
J Immunotoxicol; 2009 Dec; 6(4):205-8. PubMed ID: 19908938
[TBL] [Abstract][Full Text] [Related]
6. [Immunology: new approaches to immuno-modulation and immunotherapy].
Kabelitz D
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
[No Abstract] [Full Text] [Related]
7. Tumor immunology.
Herberman RB
JAMA; 1992 Nov; 268(20):2935-9. PubMed ID: 1433711
[No Abstract] [Full Text] [Related]
8. Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.
Reisfeld RA; Cheresh DA
Cancer Surv; 1985; 4(1):271-90. PubMed ID: 3916082
[No Abstract] [Full Text] [Related]
9. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of tumor and immune system interaction].
Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
[No Abstract] [Full Text] [Related]
11. Immune interventions in disease.
Fahey JL; Sarna G; Gale RP; Seeger R
Ann Intern Med; 1987 Feb; 106(2):257-74. PubMed ID: 2432815
[TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects of tumor immunology].
Gorodilova VV
Vopr Onkol; 1973; 19(3):9-17. PubMed ID: 4762704
[No Abstract] [Full Text] [Related]
13. Immunological approaches to the treatment of malignant disease.
Guillou PJ
J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468
[No Abstract] [Full Text] [Related]
14. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
Goldenberg DM
Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
[No Abstract] [Full Text] [Related]
15. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
16. Augmented tumor-associated antigen expression by interferons.
Borden EC
J Natl Cancer Inst; 1988 Apr; 80(3):148-9. PubMed ID: 2450206
[No Abstract] [Full Text] [Related]
17. Tumor-associated antigens and biomarkers in cancer and immune therapy.
Malyankar UM
Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
[TBL] [Abstract][Full Text] [Related]
18. Editorial overview: Tumour immunology: Are we on the path to win the battle against cancer through immunotherapy?
Jewett A
Curr Opin Immunol; 2018 Apr; 51():vii-ix. PubMed ID: 29739546
[No Abstract] [Full Text] [Related]
19. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of malignant diseases].
Dorval T; Michon J; Tartour E; Fridman WH
Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
